Wells Fargo’s Cumberland Pharmaceuticals CPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$648 Hold
100
﹤0.01% 6497
2026
Q1
$325 Buy
+100
New +$385 ﹤0.01% 6431
2025
Q2
Sell
-250
Closed -$1.06K 7174
2025
Q1
$1.06K Hold
250
﹤0.01% 6236
2024
Q4
$593 Hold
250
﹤0.01% 6302
2024
Q3
$320 Buy
+250
New +$346 ﹤0.01% 6201
2024
Q2
Sell
-65
Closed -$109 7005
2024
Q1
$109 Buy
65
+2
+3% +$4 ﹤0.01% 6632
2023
Q4
$113 Buy
63
+2
+3% +$4 ﹤0.01% 6735
2023
Q3
$115 Buy
61
+2
+3% +$3 ﹤0.01% 6733
2023
Q2
$87 Buy
59
+2
+4% +$3 ﹤0.01% 6903
2023
Q1
$111 Buy
57
+1
+2% +$2 ﹤0.01% 6910
2022
Q4
$126 Hold
56
﹤0.01% 6739
2022
Q3
$0 Sell
56
-1
-2% -$2 ﹤0.01% 6741
2022
Q2
$0 Sell
57
-1,695
-97% -$3.92K ﹤0.01% 6884
2022
Q1
$5K Buy
1,752
+1,700
+3,269% +$5.65K ﹤0.01% 6464
2021
Q4
$0 Hold
52
﹤0.01% 7284
2021
Q3
$0 Sell
52
-2,003
-97% -$5.95K ﹤0.01% 7009
2021
Q2
$6K Buy
2,055
+2,000
+3,636% +$5.88K ﹤0.01% 6274
2021
Q1
$0 Buy
55
+2
+4% +$7 ﹤0.01% 6925
2020
Q4
$0 Hold
53
﹤0.01% 6526
2020
Q3
$0 Buy
53
+2
+4% +$7 ﹤0.01% 6379
2020
Q2
$0 Hold
51
﹤0.01% 6331
2020
Q1
$0 Buy
+51
New +$228 ﹤0.01% 6259

Other funds holding CPIX

Wells Fargo's CPIX Position: Q2 2026 in Review

Wells Fargo held its Cumberland Pharmaceuticals (CPIX) position steady in Q2 2026 at 100 shares worth $648. The position accounts for ﹤0.01% of the portfolio, ranked #6497.

Wells Fargo first reported a position in CPIX in Q1 2020 and has held it in 22 quarters since. The position peaked at $6K in Q2 2021. 32 funds tracked by Wall St. Rank hold CPIX as of Q2 2026.

  • Wells Fargo held 100 shares of Cumberland Pharmaceuticals worth $648 as of Q2 2026.
  • Wells Fargo left its Cumberland Pharmaceuticals share count unchanged in Q2 2026.
  • Cumberland Pharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6497 holding.
  • Wells Fargo first reported a position in Cumberland Pharmaceuticals in Q1 2020 and has held it in 22 quarters since.
  • Wells Fargo's Cumberland Pharmaceuticals position peaked at $6K in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.